UY31601A1 - Nueva sal derivada de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]-quinolin-3-carboxamida. - Google Patents

Nueva sal derivada de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]-quinolin-3-carboxamida.

Info

Publication number
UY31601A1
UY31601A1 UY031601A UY31601A UY31601A1 UY 31601 A1 UY31601 A1 UY 31601A1 UY 031601 A UY031601 A UY 031601A UY 31601 A UY31601 A UY 31601A UY 31601 A1 UY31601 A1 UY 31601A1
Authority
UY
Uruguay
Prior art keywords
methyl
dihydroimidazo
quinolin
carboxamide
quinolinil
Prior art date
Application number
UY031601A
Other languages
English (en)
Inventor
Grahame Robert Woollam
Clare Louise Anderton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39165917&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31601(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UY31601A1 publication Critical patent/UY31601A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una sal monomaleato monohidrato de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]quinolin-3-carboxamida, a usos de la sal como un medicamento en el tratamiento de la disfunción sexual y a composiciones farmacéuticas y formas farmaceúticas que comprenden la sal.
UY031601A 2008-01-17 2009-01-15 Nueva sal derivada de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]-quinolin-3-carboxamida. UY31601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0800840.1A GB0800840D0 (en) 2008-01-17 2008-01-17 Novel salt

Publications (1)

Publication Number Publication Date
UY31601A1 true UY31601A1 (es) 2009-08-31

Family

ID=39165917

Family Applications (1)

Application Number Title Priority Date Filing Date
UY031601A UY31601A1 (es) 2008-01-17 2009-01-15 Nueva sal derivada de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]-quinolin-3-carboxamida.

Country Status (10)

Country Link
US (1) US20100317672A1 (es)
EP (1) EP2238136A1 (es)
JP (1) JP2011509973A (es)
AR (1) AR070178A1 (es)
CL (1) CL2009000075A1 (es)
GB (1) GB0800840D0 (es)
PE (1) PE20091373A1 (es)
TW (1) TW200942540A (es)
UY (1) UY31601A1 (es)
WO (1) WO2009090202A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060653A1 (es) 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1

Also Published As

Publication number Publication date
PE20091373A1 (es) 2009-10-14
TW200942540A (en) 2009-10-16
CL2009000075A1 (es) 2011-02-11
GB0800840D0 (en) 2008-02-27
WO2009090202A1 (en) 2009-07-23
AR070178A1 (es) 2010-03-17
JP2011509973A (ja) 2011-03-31
EP2238136A1 (en) 2010-10-13
US20100317672A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
EA201300121A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
UY32302A (es) Carboxamidas heterobicíclicas como inhibidoras de cinasas
CL2012001464A1 (es) Compuestos derivados de (2-amino-5,5-difluor-5,6-dihidro-4h-[1,3]oxazin-4-il)-fenilamida, inhibidores bace1 y/o bace2; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento terapeutico y/o profilactico de enfermedades tales como alzheimer y diabetes.
CR20130432A (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
CR20130588A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace 2
UY32427A (es) Composicion farmaceutica, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y usos de la misma
PE20121617A1 (es) Derivados de oxazina como inhibidores de bace
GT201200158A (es) Procedimiento para la preparación de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}metilcarbamato de metilo y su purificación para su uso como principio activo farmacéutico
UY33694A (es) ?inhibidores de n1/n2-lactama acetil-coa carboxilasa?.
DOP2013000243A (es) Inhibidores sustituidos de acetil-coa carboxilasa
MX2011009847A (es) Agentes antihelminticos y su uso.
CL2014000050A1 (es) Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson.
CU20120081A7 (es) Nuevas formas polimorfas de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo
EA201071352A1 (ru) Трициклические азотсодержащие соединения и их применение в качестве бактерицидных средств
CR20110022A (es) Nuevas posibilidades de lucha contra la giardiasis
UY31601A1 (es) Nueva sal derivada de 7-metil-6-{2-[4-(2-metil-5-quinolinil)-1-piperazinil]etil}-4,5-dihidroimidazo[1,5-a]-quinolin-3-carboxamida.
TR201309037A2 (tr) Dapoksetin ve bir pde5 inhibitörü içeren yeni efervesan saşe formülasyonları.
PE20142020A1 (es) Metodos para tratar el cancer usando inhibidor de pi3k e inhibidor de mek
BR112012031289A2 (pt) novos derivados 1,4-diazepanos, inibidores de pde-5
EA200802000A1 (ru) Фармацевтически приемлемые соли и полиморфные формы
AR075170A1 (es) Una nueva familia de antichagasicos derivados de 2,2- dioxido de imidazo (4,5-c) (1,2,6) tiadiazina
UA42862U (uk) ЗАСТОСУВАННЯ М'ЯКОЇ ЛІКАРСЬКОЇ ФОРМИ, ЯКА МІСТИТЬ АКТИВНУ РЕЧОВИНУ β-ФЕНІЛЕТИЛАМІД 2-ОКСИСУКЦИНАНІЛОВОЇ КИСЛОТИ, ДЛЯ ЛІКУВАННЯ ОПІКОВИХ УРАЖЕНЬ ШКІРИ
DOP2008000064A (es) Carboxamidas sustituidas.

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20121217